Frontlight ResearchEarly access
Trial site
Centrum Pulmonologii I Torakochirurgii W Bystrej
- 12running trials
- 5closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer17 trials
- Mesothelioma1 trial
- Neuroendocrine tumours1 trial
- Phase
- Phase 315 trials
- Phase 22 trials
- Status
- Active, not recruiting7 trials
- Completed5 trials
- Recruiting5 trials
- Lead sponsor
- AstraZeneca6 trials
- Merck Sharp & Dohme LLC4 trials
- Amgen3 trials
- F. Hoffmann-La Roche AG2 trials
- Amgen Inc.1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Active, not recruiting
Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer5 recruiting
Closed trials
Completed
Active, not recruiting
Completed
Completed
Active, not recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026